Anesthesia · Ketamine
This study could significantly influence anaesthesia practices by validating ketamine's role as an adjunct therapy, potentially altering the competitive landscape for anaesthetic agents. A successful outcome may lead to revised clinical guidelines and increased adoption of ketamine in anaesthesia protocols.
Multi-agent research across ingested FDA, EMA, MHRA, PMDA, PubMed, ClinicalTrials.gov, company documents, and Humanexa signals.
Last run 6/25/2026, 12:31:05 PM
Assessment confidence: 67% · The main uncertainty is whether clinical benefit translates into regulatory momentum and guideline influence.
This study could significantly influence anaesthesia practices by validating ketamine's role as an adjunct therapy, potentially altering the competitive landscape for anaesthetic agents. A successful outcome may lead to revised clinical guidelines and increased adoption of ketamine in anaesthesia protocols. Assessment grounded in 17 ranked evidence items (8 high-relevance).
If successful, this could lead to a shift in anaesthesia practices, enhancing the role of ketamine as an adjunct therapy, which may affect product positioning for competing anaesthetics. The strongest clinical anchor is Effect of Subanaesthetic Dose of Ketamine on Depth of Anaesthesia Consistency (ClinicalTrials.gov), entity match (ketamine). In Anesthesia · Ketamine, 0 regulatory and 4 competitive items passed relevance filtering for ketamine.
The most relevant competitive pressure comes from U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need (Pfizer) — sponsor/company relevance (pfizer). Secondary pressure from Roche's ENSPRYNG shows 68% relapse reduction in Phase III MOGAD study. This study could influence the use of ketamine in anaesthesia protocols, potentially impacting market dynamics for anaesthetic agents.
Regulatory outlook for ketamine is limited by sparse ingested precedent data.
No evidence in this category.
Effect of Subanaesthetic Dose of Ketamine on Depth of Anaesthesia Consistency
ClinicalTrials.govhigh relevance
Entity match (ketamine)
FDA document
View sourceOropharyngeoesophageal Topical Anesthesia Versus Intravenous Propofol -Ketamine Sedation for Upper Gastrointestinal Endoscopy
ClinicalTrials.govhigh relevance
Entity match (ketamine)
FDA document
View sourceRemimazolam-Flumazenil Versus Sevoflurane for Hysteroscopic Day Surgery
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View sourceStudy Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View sourcePeer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View sourceU.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
Pfizerhigh relevance
Sponsor/company relevance (Pfizer)
FDA document
View sourceRoche's ENSPRYNG shows 68% relapse reduction in Phase III MOGAD study
Humanexa Signalshigh relevance
Sponsor/company relevance (Roche)
Merck's Tulisokibart Achieves Key Endpoints in Phase 3 UC Study
Humanexa Signalshigh relevance
Sponsor/company relevance (Merck)
UK-wide ENDO1000 Study Aims to Advance Endometriosis Diagnosis and Treatment
Humanexa Signalsmedium relevance
Moderate corpus alignment
Amino acid infusion and acute kidney injury after aortic surgery: a multicenter observational study with target trial emulation.
PubMedhigh relevance
Moderate corpus alignment
FDA document
View sourceImpact of oliceridine versus sufentanil on postoperative nausea and vomiting in patients undergoing thyroid surgery: a prospective, double-blind, randomized controlled trial.
PubMedhigh relevance
Moderate corpus alignment
FDA document
View sourceDevelopment and Preliminary Clinical Evaluation of Multifunctional Operative Support Arm in Reproductive Laparoscopic Surgery: A Randomized Controlled Study.
PubMedhigh relevance
Moderate corpus alignment
FDA document
View sourceThoracic paravertebral block with different doses of liposomal bupivacaine versus ropivacaine for postoperative analgesia in single-port thoracoscopic lung surgery: a randomized clinical trial.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View sourceWarm intranasal saline irrigation reduces intraoperative blood loss during functional endoscopic sinus surgery: a propensity score-matched cohort study.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View sourceElevated ESR2 and BRCA1 gene expression in adenomyosis associated with endometrial cancer: a pilot study.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View sourceDo subjective and objective baseline sleep disturbances predict post-traumatic stress disorder treatment response? A secondary analysis of a randomized controlled trial.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View sourceNeoadjuvant immunochemotherapy and postoperative acute hypoxemic respiratory failure in thoracic surgery: a multicentre cohort study.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View sourcePrecedents · guidance
Loading regulatory precedents…
View full regulatory analysisCompetitors · threats
Loading competitive findings…
View full competitive analysisThis study could significantly influence anaesthesia practices by validating ketamine's role as an adjunct therapy, potentially altering the competitive landscape for anaesthetic agents. A successful outcome may lead to revised clinical guidelines and increased adoption of ketamine in anaesthesia protocols.
If ketamine is established as a beneficial adjunct in anaesthesia, it could enhance market positioning for ketamine and affect sales of competing anaesthetic agents like propofol.
The study is unlikely to lead to immediate regulatory changes but may inform future clinical guidelines and practices in anaesthesia management.
Monitor results from the trial for efficacy outcomes and any changes in clinical practice guidelines regarding anaesthesia management.
Track for follow-up milestones; no immediate action required.